Skip to content

The effect of Laser on the clinical treatment of secondary Lymphedema of legs

The effect of Photobiomodulation on the clinical treatment of secondary Lymphedema of lower limbs

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4yyktr
Enrollment
Unknown
Registered
2020-08-12
Start date
2020-03-09
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of the circulatory system

Interventions

Patients will be referred by the medical team and will undergo a physical therapy/lymphedema evaluation, prepared by the researchers, where personal data, clinical history, specific information about
they will also answer the Lymphedema Functioning, Disability and Health Questionnaire for Lower Limb Lymphedema - Lymph-ICF-LL23 and will be classified according to their skin phototype (Fitzpatrick S
Photobiomodulation group (PG) composed of 15 patients who will undergo complex physical therapy and photo
Other
E07.632.490
E02.774

Sponsors

Universidade Federal de São Paulo
Lead Sponsor
Universidade Federal de São Paulo
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with unilateral or bilateral lymphedema of the lower limbs due to secondary causes; Over 18 years of age; Agreement in participating in the study; Mowlem I and II or according to the International Society of Lymphology stage I and II

Exclusion criteria

Exclusion criteria: Patients with uncontrolled renal, cardiac or pulmonary disorders; Uncontrolled hypertensive patients; Patients with polyneuropathies; Pregnant women, and infants; Patient with active infection and open wounds; Patients who abandon treatment, and or attendance below 70%; Patients with primary lymphedema; Patients who have received previous treatment at least 3 months ago

Design outcomes

Primary

MeasureTime frame
To assess whether photobiomodulation when combined with complex decongestive physical therapy improves the outcome of treatment for secondary lower limb lymphedema after four weeks. The results will be evaluated using the Lymph-ICF-LL questionnaire, direct and indirect volumetry.

Secondary

MeasureTime frame
Secondary outcomes are not expected.

Countries

Brazil

Contacts

Public ContactMaria de Andrade Lucena

Universidade Federal de São Paulo

gabrielalucena2205@gmail.com+55-011-55764848

Outcome results

None listed

Source: REBEC (via WHO ICTRP)